Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABRAFENIB for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 15 adverse event reports in the FDA FAERS database where DABRAFENIB was used for Prostate cancer.

Most Reported Side Effects for DABRAFENIB

Side Effect Reports % Deaths Hosp.
Pyrexia 3,788 19.6% 352 1,599
Death 2,740 14.2% 2,733 198
Malignant neoplasm progression 1,667 8.6% 693 496
Fatigue 1,328 6.9% 135 338
Nausea 1,300 6.7% 178 450
Chills 1,235 6.4% 90 419
Rash 1,078 5.6% 82 244
Vomiting 907 4.7% 122 445
Diarrhoea 901 4.7% 103 357
Headache 697 3.6% 69 228
Asthenia 667 3.5% 124 289
Malaise 585 3.0% 86 237
Decreased appetite 546 2.8% 110 215
Arthralgia 539 2.8% 40 146
Product use in unapproved indication 504 2.6% 94 60

Other Indications for DABRAFENIB

Malignant melanoma (5,277) Product used for unknown indication (4,430) Metastatic malignant melanoma (3,885) Lung neoplasm malignant (610) Thyroid cancer (583) Non-small cell lung cancer (557) Neoplasm malignant (356) Braf gene mutation (224) Braf v600e mutation positive (213) Malignant melanoma stage iv (197)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

DABRAFENIB Full Profile All Prostate cancer Drugs DABRAFENIB Demographics DABRAFENIB Timeline